NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Matter Bio

Matter Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.matter.bio/

Last Round

Seed

May 29, 2024

Total Funding Raised

$7M

Company Overview

Matter Bio is a biotechnology company that develops therapeutic interventions and research services aimed at preserving genome integrity to extend human healthspan and treat age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

genomic medicinegenetic engineeringbiotechnologytherapeutic pipelinesomatic mutationmutation sequencingcellular therapydrug discoveryprecision medicinegenomicsDNA repairbiotech R&Dlongevity sciencegenomic databiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Matter Bio Comparables

Compare Matter Bio with similar companies based on industry and business-model similarity.

Matter Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Turn Biotechnologies
71%
Editas Medicine
70%
Fauna Bio
70%

Matter Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 29, 2024

Key People

Founding team and executive leadership

Sam Sharifi

Chief Scientific Officer & Co-founder

Founding Team

Christopher Bradley

CEO & Co-Founder

Founding Team

Matter Bio Investors

Notable investors and investment history

Matter Bio investors
InvestorRounds
LifeSpan Vision VenturesSeed
quadraScope VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 29, 2024

    $7M round led by LifeSpan Vision Ventures

Matter Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Matter Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Matter Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2022
Last FundingMay 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.